RS3826884 Unknown gene

Other Chr ?:?
Upload your DNA to see your genotype for this variant.
GWAS Studies (13)
Trait Risk Allele OR / Beta P-value Study
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) levels A OR: 0.2 1E-23 PubMed
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levels A OR: 0.19 5E-21 PubMed
Metabolite levels (1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)) A OR: 0.2 6E-18 PubMed
Hypothyroidism A β: 0.048 2E-14 PubMed
1-(1-enyl-palmitoyl)-GPE (p-16:0) levels A β: 0.099 4E-14 PubMed
Phosphatidylethanolamine (O-16:1_20:4) levels A OR: 0.18 4E-14 PubMed
Phosphatidylethanolamine-O_34:3_[M-H]1-/Phosphatidylethanolamine-P_34:2_[M-H]1- levels A OR: 0.11 1E-13 PubMed
Metabolite levels (1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2); C34:3 PE plasmalogen) A OR: 0.16 1E-13 PubMed
Serum metabolite levels G OR: 0.2 2E-13 PubMed
Serum metabolite levels G OR: 0.2 2E-13 PubMed
Phosphatidylethanolamine-O_36:5_[M-H]1-/Phosphatidylethanolamine-P_36:4_[M-H]1- levels A β: 0.099 4E-11 PubMed
Alkenylphosphatidylethanolamine (P-16:0/18:1) levels A OR: 0.17 3E-9 PubMed
Phosphatidylethanolamine (O-16:1_20:4) levels A OR: 0.17 3E-8 PubMed
Ask Dr. Hemsworth about this variant